Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

BioSenic files for additional patent protection following new clinical evidence of efficacy for JTA-004 in osteoarthritis

Date
Tue, 01/23/2024 - 12:00
Year
2024
Filter Criteria
Press Releases
Document Upload
BIOS_PR_2024-01-23_JTA Patent Severe OA_EN_Final.pdf253.47 KB
Wallonie Eu Flag

BioSenic SA
Avenue Léon champagne, 3
1480 Saintes – Belgium
info@biosenic.com
 

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions